Table 2 Compliance to adjuvant hormone therapy by patient characteristics
Total N | Not compliant | Compliant | OR | 95% CI | |
|---|---|---|---|---|---|
Age in years | |||||
39-50 | 18 | 1 (5.6%) | 17 (94.4%) | 1.0 (Ref) | |
51-60 | 81 | 12 (14.8%) | 69(85.2%) | 0.34 | 0.41-2.78 |
61-74 | 61 | 7 (11.5%) | 54 (88.5%) | 0.45 | 0.05-3.95 |
Race/Ethnicity | |||||
White | 116 | 14 (12.1%) | 102 (87.9%) | 1.0 (Ref) | |
Black | 46 | 6 (13.0%) | 40 (87.0%) | 0.92 | 0.33-2.55 |
Insurance coverage on prescriptions | |||||
None | 2 | 0 (0%) | 2 (100%) | 1.0 (Ref) | |
Some | 37 | 5 (13.5%) | 32 (86.5%) | 0.46 | 0.05-4.28 |
Most | 105 | 14 (13.3%) | 91 (86.7%) | 1.45 | 0.06-3.81 |
All | 15 | 1 (6.7%) | 14 (93.3%) | - | - |
Family income | |||||
<$60 K | 61 | 5 (8.2%) | 56 (91.8%) | 1.0 (Ref) | |
$60 K+ | 91 | 13 (14.3%) | 78 (85.7%) | 0.54 | 0.18-1.59 |
Education level | |||||
< High school | 15 | 1 (6.7%) | 14 (93.3%) | 1.0 (Ref) | |
High School Graduate | 65 | 7 (10.8%) | 58 (89.2%) | 0.59 | 0.07-5.21 |
Bachelor’s Degree | 33 | 5(15.2%) | 28(84.9%) | 0.40 | 0.04-3.76 |
Graduate Degree | 49 | 7 (14.3%) | 42 (85.7%) | 0.42 | 0.05-3.79 |
Comorbid Medical Conditions | |||||
None | 54 | 6 (11.1%) | 48 (88.9%) | 1.0 (Ref) | |
≥1comorbid conditions | 108 | 14 (13.0%) | 94 (87.0%) | 0.84 | 0.30-2.32 |
Out of pocket expenses | |||||
None | 1 | 0 (0%) | 1 (100%) | ||
<$50/month | 60 | 8 (13.3%) | 52 (86.7%) | 1.0 (Ref) | |
$50-100/month | 47 | 6 (12.8%) | 41 (87.2%) | 1.05 | 0.34-3.27 |
$100-150/month | 26 | 2 (7.7%) | 24 (92.3%) | 1.84 | 0.36-9.36 |
$150-200/month | 8 | 2(25.0%) | 6 (75.0%) | 0.46 | 0.08-2.70 |
>$200/month | 8 | 0 (0%) | 8 (100%) | - | - |
Perceived importance of therapy | |||||
Not important | 9 | 4 (44.4%) | 5 (55.6%) | 1.0 (Ref) | |
A little important | 7 | 3 (42.9%) | 4 (57.1%) | 1.07 | 0.14-7.82 |
Moderately important | 38 | 5(13.2%) | 33 (86.8%) | 5.28 | 1.05-26.6 |
Very important | 104 | 7 (6.7%) | 97 (93.3%) | 11.1 | 2.42-50.8 |
Concern about cancer recurrence | |||||
Not worried | 51 | 6 (11.8%) | 45 (88.2%) | 1.0 (Ref) | |
Somewhat worried | 86 | 13 (15.1%) | 73 (84.9%) | 0.75 | 0.27-2.11 |
Very worried | 24 | 1 (4.2%) | 23 (95.8%) | 0.75 | 0.35-27.0 |
Concern about side effects | |||||
Not concerned | 40 | 4 (10.0%) | 36 (90.0%) | 1.0 (Ref) | |
Small concerns | 50 | 6 (12.0%) | 44 (88.0%) | 0.81 | 0.21-3.11 |
Moderate concerns | 42 | 2 (4.8%) | 40 (95.2%) | 2.22 | 0.38-12.9 |
Big concerns | 29 | 8 (27.6%) | 21 (72.4%) | 0.29 | 0.08-1.09 |
Value placed on doctor’s opinion | |||||
Not at all | 7 | 6 (85.7%) | 1 (14.3%) | 1.0 (Ref) | |
Partly | 23 | 5 (21.7%) | 18 (78.3%) | 21.6 | 2.09-223.7 |
Almost entirely | 131 | 9 (6.9%) | 122 (93.1%) | 81.3 | 8.81-750.8 |